Nippon Shinyaku Co
Nippon Shinyaku Co., Ltd., commonly referred to as Nippon Shinyaku, is a prominent pharmaceutical company headquartered in Japan. Established in 1923, the company has made significant strides in the healthcare sector, focusing on the development and manufacturing of innovative pharmaceuticals and medical devices. With a strong presence in both domestic and international markets, Nippon Shinyaku operates extensively across Asia, Europe, and North America. The company is renowned for its core products, which include prescription medications, particularly in the fields of oncology, urology, and orthopaedics. Nippon Shinyaku's commitment to research and development has positioned it as a leader in the pharmaceutical industry, with notable achievements in drug discovery and a robust pipeline of new therapies. Through its dedication to improving patient outcomes, Nippon Shinyaku continues to enhance its market position as a trusted provider of high-quality healthcare solutions.
DitchCarbon Score
How does Nippon Shinyaku Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Nippon Shinyaku Co's score of 45 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Nippon Shinyaku Co's reported carbon emissions
In 2023, Nippon Shinyaku Co., Ltd. reported total greenhouse gas emissions of approximately 4910000 kg CO2e for Scope 1 and about 5204000 kg CO2e for Scope 2, with a significant Scope 3 total of approximately 217585000 kg CO2e. The combined emissions for Scope 1 and 2 amounted to about 6803000 kg CO2e. The company has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by FY2030, using FY2020 as the base year. Additionally, Nippon Shinyaku is committed to a 25% reduction in absolute Scope 3 emissions from purchased goods and services within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are designed to contribute to limiting global warming to 1.5°C. Nippon Shinyaku's emissions data is self-reported and does not cascade from any parent organization. The company is actively working towards its sustainability goals within the pharmaceuticals, biotechnology, and life sciences sector, reflecting a commitment to environmental responsibility and climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 428,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | - | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | 00,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Nippon Shinyaku Co is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
